Imbalance of testosterone/estradiol promotes male CHD development

Bio-Medical Materials and Engineering

Volumn 22, Issue 1-3, 2012, Pages 179-185

  Zheng, Hong Yun ^a   Li, Yan ^a   Dai, Wen ^a   Wei, Chuan Dong ^a   Sun, Kai Sheng ^a   Tong, Yong Qing ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Coronary heart disease; estradiol; imbalance; men; testosterone

Indexed keywords

CORONARY HEART DISEASE; ESTRADIOL; IMBALANCE; MEN; TESTOSTERONE;

BODY FLUIDS; CARDIOVASCULAR SYSTEM;

LINEAR REGRESSION;

ESTRADIOL; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TESTOSTERONE; TRIACYLGLYCEROL;

ARTICLE; BLOOD; BODY MASS; CORONARY ARTERY DISEASE; HUMAN; MALE; MIDDLE AGED; RISK FACTOR; STATISTICAL MODEL;

BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CORONARY DISEASE; ESTRADIOL; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; LINEAR MODELS; LIPOPROTEINS; MALE; MIDDLE AGED; RISK FACTORS; TESTOSTERONE; TRIGLYCERIDES;

EID: 84863665656     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: 10.3233/BME-2012-0705     Document Type: Conference Paper

References (32)

1. D.J. Lerner andW.B. Kannel, Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population, Am. Heart J. 111(2) (1986), 383-390.
2. E. Wehr, S. Pilz, B.O. Boehm et al., Low free testosterone is associated with heart failure mortality in older men referred for coronary angiography, Eur. J. Heart Fail. 13(5) (2011), 482-488.
3. C. Vitale, M.E. Mendelsohn and G.M. Rosano, Gender differences in the cardiovascular effect of sex hormones, Nat. Rev. Cardiol. 6(8) (2009), 532-542.
4. J. Sagrista-Sauleda, J. Angel, A. Sambola et al., Hemodynamic effects of volume expansion in patients with cardiac tamponade, Circulation 117(12) (2008), 1545-1549.
5. E.R. Simpson, Sources of estrogen and their importance, J. Steroid Biochem. Mol. Biol. 86(3-5) (2003), 225-230.
6. J. Fujimoto, M. Nishigaki, M. Hori et al., The effect of estrogen and androgen on androgen receptors and mRNA levels in uterine leiomyoma, myometrium and endometrium of human subjects, J. Steroid Biochem. Mol. Biol. 50(3,4) (1994), 137-143.
7. S.E. Bulun, S. Sebastian, K. Takayama et al., The human CYP19 (aromatase P450) gene: update on physiologic roles and genomic organization of promoters, J. Steroid Biochem. Mol. Biol. 86(3-5) (2003), 219-224.
8. A. Negre-Salvayre, M.T. Pieraggi, L. Mabile et al., Protective effect of 17 beta-estradiol against the cytotoxicity of minimally oxidized LDL to cultured bovine aortic endothelial cells, Atherosclerosis 99(2) (1993), 207-217.
9. L.A. Huber, E. Scheffler, T. Poll et al., 17 beta-estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages, Free Radic. Res. Commun. 8(3) (1990), 167-173.
10. Third Report of the National Cholesterol Education Program (NCEP), Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report, Circulation 106(25) (2002), 3143-3421.
11. D. Javeshghani, M.R. Sairam, E.L. Schiffrin et al., Increased blood pressure, vascular inflammation, and endothelial dysfunction in androgen-deficient follitropin receptor knockout male mice, J. Am. Soc. Hypertens. 1(5) (2007), 353-361.
12. A.M. Traish, R. Abdou and K.E. Kypreos, Androgen deficiency and atherosclerosis: The lipid link, Vascul. Pharmacol. 51(5,6) (2009), 303-313.
13. A.M. Traish, R.J. Feeley and A. Guay, Mechanisms of obesity and related pathologies: androgen deficiency and endothelial dysfunction may be the link between obesity and erectile dysfunction, FEBS J. 276(20) (2009), 5755-5767.
14. A.M. Traish, F. Saad, R.J. Feeley et al., The dark side of testosterone deficiency: III. Cardiovascular disease, J. Androl. 30(5) (2009), 477-494.
15. D.N. Krause, S.P. Duckles and D.A. Pelligrino, Influence of sex steroid hormones on cerebrovascular function, J. Appl. Physiol. 101(4) (2006), 1252-1261.
16. N. Geary, The effect of estrogen on appetite, Medscape Womens Health 3(6) (1998), 3.
17. A.M. McNeill, N. Kim, S.P. Duckles et al., Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels, Stroke 30(10) (1999), 2186-2190.
18. G.G. Geary, D.N. Krause and S.P. Duckles, Estrogen reduces mouse cerebral artery tone through endothelial NOS-and cyclooxygenase-dependent mechanisms, Am. J. Physiol. Heart Circ. Physiol. 279(2) (2000), H511-H519.
19. A. Razmara, D.N. Krause and S.P. Duckles, Testosterone augments endotoxin-mediated cerebrovascular inflammation in male rats, Am. J. Physiol. Heart Circ. Physiol. 289(5) (2005), H1843-H1850.
20. M.R. Sowers, J. Randolph, Jr., M. Jannausch et al., Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis", Arch. Intern. Med. 168(19) (2008), 2146-2153.
21. W.T. Friedewald, R.I. Levy and D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin. Chem. 18(6) (1972), 499-502.
22. E.Q. Callou de Sa, F.C. de Sa, R.D. Silva et al., Endogenous oestradiol but not testosterone is related to coronary artery disease in men sex hormones and coronary artery disease, Clin. Endocrinol. (Oxf.) 75(2) (2011), 177-183.
23. M.D. Schwarcz and W.H. Frishman, Testosterone and coronary artery disease, Cardiol. Rev. 18(5) (2010), 251-257.
24. J. Arnlov, M.J. Pencina, S. Amin et al., Endogenous sex hormones and cardiovascular disease incidence in men, Ann. Intern. Med. 145(3) (2006), 176-184.
25. J.A. Cauley, J.P. Gutai, L.H. Kuller et al., Usefulness of sex steroid hormone levels in predicting coronary artery disease in men, Am. J. Cardiol. 60(10) (1987), 771-777.
26. K. Sudhir and P.A. Komesaroff, Clinical review 110: Cardiovascular actions of estrogens in men, J. Clin. Endocrinol. Metab. 84(10) (1999), 3411-3415.
27. F.M. Sacks and B.W. Walsh, Sex hormones and lipoprotein metabolism, Curr. Opin. Lipidol. 5(3) (1994), 236-240.
28. P.W. Shaul, Novel role of estrogen receptors in vascular endothelium, Semin. Perinatol. 24(1) (2000), 70-74.
29. P.M. Ridker, M. Cushman,M.J. Stampfer et al., Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men, N. Engl. J. Med. 336(14) (1997), 973-979.
30. S. Turhan, C. Tulunay, S. Gulec et al., The association between androgen levels and premature coronary artery disease in men, Coron. Artery Dis. 18(3) (2007), 159-162.
31. T. Vikan, H. Schirmer, I. Njolstad et al., Endogenous sex hormones and the prospective association with cardiovascular disease and mortality in men: the Tromso study, Eur. J. Endocrinol. 161(3) (2009), 435-442.
32. V. Guarner-Lans, M.E. Rubio-Ruiz, I. Perez-Torres et al., Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease, Exp. Gerontol. 46(7) (2011), 517-523.